SA

Suresh Anitha

Active Director Director DIN 07312194
DIN 07312194 First appointment Oct 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2015
Shareholding value •••• Premium profile

About Suresh Anitha

Data last updated:

Suresh Anitha is a Director at Instat Clinical Research Private Limited (since 2015). The company operates in Pharma. Instat Clinical Research Private Limited reported revenue of ₹7.32 Cr (FY 2024).

DIN 07312194
Primary Designation Director
Industry Pharma
First Appointment 27 Oct 2015
Oldest Company Age 10 yrs
Largest company Instat Clinical Research Private Limited · ₹7.32 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Oct 20152015₹7.32 Cr (FY 2024)Active

Board colleagues of Suresh Anitha

Directorship timeline

Open interactive timeline →
Instat Clinical Research Private Limited
Premium access

Shareholding and investment profile for Suresh Anitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Anitha

Suresh Anitha currently holds 1 directorship: Instat Clinical Research Private Limited (Director, since 27 Oct 2015, revenue ₹7.32 Cr (FY 2024)).

Suresh Anitha was first appointed on 27 Oct 2015 as Director at Instat Clinical Research Private Limited.

The current boards of Suresh Anitha's companies include Cynthia Marie Henderson (Instat Clinical Research Private Limited), Patrick Thomas Flanagan (Instat Clinical Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available